SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2020
Commission File Number 000-56026
TODOS MEDICAL LTD.
(Translation of registrant’s name into English)
1 Hamada Street
Rehovot, Israel 7670301
Tel: (011) (972) 8-633-3964
(Address of Principal Executive Offices)
|Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:|
|[X] Form 20-F||[ ] Form 40-F|
|Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____|
|Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____|
Extraordinary General Meeting
The Company hereby furnishes the following documents:
(a) Notice and Proxy Statement with respect to the Company’s Extraordinary General Meeting of Shareholders to be held on May 11, 2020. The Proxy Statement describes the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy, and various other details related to the meeting; and
(b) A Proxy Card whereby holders of the Company’s shares may vote at the meeting without attending in person.
Financial Statements and Exhibits.
The following Exhibits are filed as part of this Report.
|99.2||Proxy Card for the Extraordinary General Meeting of Shareholders of the Company to be held on May 11, 2020|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|TODOS MEDICAL LTD.|
|By:||/s/ Gerald Commissiong|
|Title:||Chief Executive Officer|
|Date: April 14, 2020|